Nitrous oxide 50% with oxygen 50% (Entonox) cylinders size D,F,G
Note: MHRA safety notice Neurological and haematological toxic effects can occur with prolonged use of nitrous oxide. Neurological effects can occur without preceding overt haematological changes. Assessment of vitamin B12 levels should be considered before nitrous oxide anaesthesia in people with risk factors for deficiency.
Oral solutionSF 10mg in 5ml prohibitively expensive (Aug 19)
Loprazolam & temazepam both have short duration of action and have no active metabolites.
Temazepam is a Schedule 3 controlled drug; a maximum of 30 days supply for all controlled drugs is the good practice advice from the Department of Health. Ref: Safer Management of Controlled Drugs, May 2007
30mg in 1ml amp
Licensed for use in short-term management of moderate to severe post operative pain only.
Contains a small amount of ethanol per dose (100mg)
See palliative care section Chapter 21
1mg in 2ml amp
5mg in 10ml amp
5mg in 1ml amp intensive care injection
Note - also included as an AMBER TLS drug in SWINDON ONLY for use in palliative care. See here
100 micrograms in 2ml amp
500 micrograms in 10ml amp
Other drugs for sedation
GWH ICU/theatres only
100 micrograms/ml concentrate for solution for infusion, various ampoule sizes
Neuromuscular blocking drugs
Non-depolarising muscle relaxants
25mg in 2.5ml amp
50mg in 5ml amp
250mg in 25ml vial
2mg/ml or 5mg/ml
Injection 2 mg/ml
2mg in 1ml
4mg in 2ml
50mg in 5ml vial
10mg injection vial
Depolarising muscle relaxants
100mg in 2ml amp
Drugs for reversal of neuromuscular blockade
2.5mg in 1ml injection
Neostigmine with Glycopyrronium
500 micrograms in 1ml amp
Other drugs for reversal of neuromuscular blockade
100mg/ml injection 1ml, 2ml or 5ml vials
Antagonists for central and respiratory depression
500 micrograms in 5ml amp
Used to reverse the effects of benzodiazepines. See SPC for full information on safe use.
RED - Hospital only – to be prescribed by a specialist and supplied from secondary care ONLY throughout treatment.
Amber medicines are considered suitable for GP prescribing following specialist initiation or recommendation.
Shared Care - these medicines require specialist initiation and stabilisation. Ongoing division of responsibility for drug and disease monitoring between specialist and GP by a Shared Care Guideline (SCG). If no SCG in place status reverts to red.
These medicines are appropriate for initiation in both primary and secondary care. Prescribing is appropriate within licensed or local recommendations.
Suitable for patient to be directed to buy themselves
Not currently used. We intend to include this TLS in future to highlight where a decision to use this medicine is under review.
(In use from Oct 2020) Used where a decision has been made by the BSW APC not to routinely commission this preparation for its licensed indications. Do not prescribe.
Not currently used. We intend to include this TLS in future to highlight where this medicine and indication is ONLY available through a Specialist Centre according to a NICE Highly Specialised Technology or NHSE Specialised Commission Circular / Policy.